Author

T. R. Fuerst

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Organism:non-human primate· 1

Frequent Co-Authors

R. Wang· 3 shared E. A. Toth· 2 shared A. C. Lemmer· 1 shared A. K. Andrianov· 1 shared A. Marin· 1 shared B. M. Janus· 1 shared B. Pierce· 1 shared B. Ruan· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

R. Wang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cross-reactive macaque antibodies targeting marburgvirus glycoprotein induced by multivalent immunization

B. M. Janus, R. Wang, T. E. Cleveland, M. C. Metcalf, A. C. Lemmer, K. Class, T. R. Fuerst, G. Ofek

This study isolates and characterizes a diverse panel of marburgvirus glycoprotein-specific monoclonal antibodies from a Rhesus macaque immunized with multivalent filovirus antigens, revealing novel epitopes and potential therapeutic candidates.

bioRxiv · Sep 23, 2023 · PreprintImmunology

Engineering protein-specific proteases: targeting active RAS

Y. Chen, E. A. Toth, B. Ruan, E. J. Choi, R. Simmerman, Y. Chen, Y. He, R. Wang, R. Godoy-Ruiz, H. King, G. Custer, D. T. Gallagher, D. A. Rozak, M. Soloman, S. Muro, , P. N. Bryan

This study designs engineered proteases that specifically degrade active RAS by cleaving a conserved sequence in switch 2, showing efficacy in vitro and in human cell culture.

bioRxiv · Sep 21, 2020Biochemistry

Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization

B. Pierce, Z.-y. Keck, R. Wang, P. Lau, K. J. Garagusi, K. Elkholy, E. A. Toth, R. A. Urbanowicz, J. D. Guest, P. Agnihotri, M. C. Kerzic, A. Marin, A. K. Andrianov, J. K. Ball, R. Mariuzza, , S. Foung

The paper designs optimized HCV E2 glycoproteins to enhance binding and cross-neutralization by modifying antigenic sites and testing immunogenicity in mice.

bioRxiv · Apr 15, 2020Microbiology